Home » Topics » BioWorld Science

BioWorld Science
RSS

Pierre Fabre and Merck & Co. sign agreement for F-50035

Aug. 9, 2004

Active Pass researchers describe new antiamyloidogenic agents

Aug. 9, 2004

Orphan drug designation for ambrisentan for PAH

Aug. 9, 2004

New histamine H3 ligands and their use in obesity and other disorders

Aug. 9, 2004

Sigma-Tau presents novel agents for diabetes, obesity, etc.

Aug. 9, 2004

Micrologix Biotech and Strata enter agreement for MBI-226

Aug. 9, 2004

New KSP inhibitors jointly reported by GSK and Cytokinetics

Aug. 9, 2004

Funding at Pepgen to support advancement of Tauferon

Aug. 9, 2004

Sculptra receives FDA approval for lipoatrophy

Aug. 9, 2004

South African HIV trial of VGV-1 commences enrollment

Aug. 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...